378 related articles for article (PubMed ID: 28759388)
1. Genomic approaches to accelerate cancer interception.
Beane J; Campbell JD; Lel J; Vick J; Spira A
Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
[TBL] [Abstract][Full Text] [Related]
2. The Case for a Pre-Cancer Genome Atlas (PCGA).
Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
[TBL] [Abstract][Full Text] [Related]
3. Cancer risk assessment and cancer prevention: promises and challenges.
Reid BJ
Cancer Prev Res (Phila); 2008 Sep; 1(4):229-32. PubMed ID: 19138965
[No Abstract] [Full Text] [Related]
4. Genomic studies track early hints of cancer.
Ledford H
Nature; 2017 Oct; 551(7678):18. PubMed ID: 29094716
[No Abstract] [Full Text] [Related]
5. Early Events in the Molecular Pathogenesis of Lung Cancer.
Kadara H; Scheet P; Wistuba II; Spira AE
Cancer Prev Res (Phila); 2016 Jul; 9(7):518-27. PubMed ID: 27006378
[TBL] [Abstract][Full Text] [Related]
6. Genetic and familial cancer: opportunities for prevention and early detection.
Li FP
Cancer Detect Prev; 1986; 9(1-2):41-5. PubMed ID: 3731193
[TBL] [Abstract][Full Text] [Related]
7. The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients.
Hopman SM; Merks JH; de Borgie CA; Aalfs CM; Biesecker LG; Cole T; Eng C; Legius E; Maher ER; van Noesel MM; Verloes A; Viskochil DH; Wagner A; Weksberg R; Caron HN; Hennekam RC
Eur J Cancer; 2013 Oct; 49(15):3247-54. PubMed ID: 23855994
[TBL] [Abstract][Full Text] [Related]
8. The path to routine use of genomic biomarkers in the cancer clinic.
Boutros PC
Genome Res; 2015 Oct; 25(10):1508-13. PubMed ID: 26430161
[TBL] [Abstract][Full Text] [Related]
9. Blueprint for cancer research: Critical gaps and opportunities.
Elmore LW; Greer SF; Daniels EC; Saxe CC; Melner MH; Krawiec GM; Cance WG; Phelps WC
CA Cancer J Clin; 2021 Mar; 71(2):107-139. PubMed ID: 33326126
[TBL] [Abstract][Full Text] [Related]
10. The molecular pathology of cancer: from pan-genomics to post-genomics.
Huntsman DG; Ladanyi M
J Pathol; 2018 Apr; 244(5):509-511. PubMed ID: 29436707
[TBL] [Abstract][Full Text] [Related]
11. Genomics of Esophageal Cancer and Biomarkers for Early Detection.
Pusung M; Zeki S; Fitzgerald R
Adv Exp Med Biol; 2016; 908():237-63. PubMed ID: 27573775
[TBL] [Abstract][Full Text] [Related]
12. Update on cholangiocarcinoma: potential impact of genomic studies on clinical management.
Walter D; Hartmann S; Waidmann O
Z Gastroenterol; 2017 Jun; 55(6):575-581. PubMed ID: 28376540
[TBL] [Abstract][Full Text] [Related]
13. Lung Cancer and Immunity Markers.
Lim RJ; Liu B; Krysan K; Dubinett SM
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2423-2430. PubMed ID: 32856614
[TBL] [Abstract][Full Text] [Related]
14. Translating genomic risk into an early detection strategy for sarcoma.
Ballinger ML; Pinese M; Thomas DM
Genes Chromosomes Cancer; 2019 Feb; 58(2):130-136. PubMed ID: 30382615
[TBL] [Abstract][Full Text] [Related]
15. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
16. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
Ow TJ; Sandulache VC; Skinner HD; Myers JN
Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
[TBL] [Abstract][Full Text] [Related]
17. Editorial.
Baxter G
Clin Radiol; 2017 Jan; 72(1):1-2. PubMed ID: 27836105
[No Abstract] [Full Text] [Related]
18. The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
Ryan BM; Faupel-Badger JM
Semin Oncol; 2016 Feb; 43(1):22-35. PubMed ID: 26970122
[TBL] [Abstract][Full Text] [Related]
19. Advances and challenges in cancer immunoprevention and immune interception.
Stanton SE; Castle PE; Finn OJ; Sei S; Emens LA
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38519057
[TBL] [Abstract][Full Text] [Related]
20. Transforming Cancer Prevention through Precision Medicine and Immune-oncology.
Kensler TW; Spira A; Garber JE; Szabo E; Lee JJ; Dong Z; Dannenberg AJ; Hait WN; Blackburn E; Davidson NE; Foti M; Lippman SM
Cancer Prev Res (Phila); 2016 Jan; 9(1):2-10. PubMed ID: 26744449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
